FAFGX | QALGX | FAFGX / QALGX | |
Total Expense Ratio | 0.40 | 1.00 | 40% |
Annual Report Gross Expense Ratio | 0.40 | 1.13 | 35% |
Fund Existence | 5 years | 20 years | - |
Gain YTD | 11.291 | 8.774 | 129% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 250 | 1500 | 17% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 323B | 3.07B | 10,535% |
Annual Yield % from dividends | 0.53 | 0.00 | - |
Returns for 1 year | 11.14 | 14.19 | 78% |
Returns for 3 years | 61.52 | 72.75 | 85% |
Returns for 5 years | N/A | 54.45 | - |
Returns for 10 years | N/A | 108.52 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BFTUX | 64.66 | 1.05 | +1.65% |
Baron Fifth Avenue Growth R6 | |||
PCEKX | 24.55 | 0.14 | +0.57% |
Victory Pioneer Core Equity R6 | |||
PEIJX | 41.73 | 0.19 | +0.46% |
Principal Equity Income J | |||
NIEYX | 18.23 | 0.04 | +0.22% |
BNY Mellon International Equity Y | |||
LYFCX | 11.94 | -0.01 | -0.08% |
AlphaCentric Life Sciences & Hlthcare C |